Brain Health and Cognitive Function While still an emerging area of research, GLP-1 medications may offer benefits for brain health
A qualified healthcare provider evaluates cardiovascular risk, kidney function, gastrointestinal history, and family history of medullary thyroid carcinoma before prescription
Ongoing Evaluation of Monlunabant The ongoing evaluation of Monlunabant in upcoming studies is crucial to fully understand its safety and effectiveness
Novo Nordisk insists that the benefit-risk profile of semaglutide, the active ingredient in Ozempic, remains unchanged and stresses that patient safety is a priority
Flexible pathways, not pressure Women do best when they can shift between microdosing, full dose, oral options, or taper plans based on how their body feels, instead of being locked into one approach